150 related articles for article (PubMed ID: 38246990)
21. KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c-Myc.
Kim EJ; Kim SH; Jin X; Jin X; Kim H
Cell Death Differ; 2017 Apr; 24(4):649-659. PubMed ID: 28060381
[TBL] [Abstract][Full Text] [Related]
22. Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc.
Bian E; Chen X; Cheng L; Cheng M; Chen Z; Yue X; Zhang Z; Chen J; Sun L; Huang K; Huang C; Fang Z; Zhao B; Li J
J Exp Clin Cancer Res; 2021 Oct; 40(1):337. PubMed ID: 34696771
[TBL] [Abstract][Full Text] [Related]
23. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
[TBL] [Abstract][Full Text] [Related]
24. Reciprocal activation of transcription factors underlies the dichotomy between proliferation and invasion of glioma cells.
Dhruv HD; McDonough Winslow WS; Armstrong B; Tuncali S; Eschbacher J; Kislin K; Loftus JC; Tran NL; Berens ME
PLoS One; 2013; 8(8):e72134. PubMed ID: 23967279
[TBL] [Abstract][Full Text] [Related]
25. Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.
Wang H; Tao Z; Feng M; Li X; Deng Z; Zhao G; Yin H; Pan T; Chen G; Feng Z; Li Y; Zhou Y
Biochem Biophys Res Commun; 2020 Dec; 533(3):368-375. PubMed ID: 32962858
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-98 Attenuates Cell Migration and Invasion in Glioma by Directly Targeting Pre-B Cell Leukemia Homeobox 3.
Xu X; Bao Z; Liu Y; Ji J; Liu N
Cell Mol Neurobiol; 2017 Nov; 37(8):1359-1371. PubMed ID: 28124208
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of SNRPG induces cell cycle arrest and sensitizes human glioblastoma cells to temozolomide by targeting Myc through a p53-dependent signaling pathway.
Lan Y; Lou J; Hu J; Yu Z; Lyu W; Zhang B
Cancer Biol Med; 2020 Feb; 17(1):112-131. PubMed ID: 32296580
[No Abstract] [Full Text] [Related]
28. Integrative analysis of cell adhesion molecules in glioblastoma identified prostaglandin F2 receptor inhibitor (PTGFRN) as an essential gene.
Mala U; Baral TK; Somasundaram K
BMC Cancer; 2022 Jun; 22(1):642. PubMed ID: 35690717
[TBL] [Abstract][Full Text] [Related]
29. Hypoxic Glioma Stem Cell-Derived Exosomes Containing Linc01060 Promote Progression of Glioma by Regulating the MZF1/c-Myc/HIF1α Axis.
Li J; Liao T; Liu H; Yuan H; Ouyang T; Wang J; Chai S; Li J; Chen J; Li X; Zhao H; Xiong N
Cancer Res; 2021 Jan; 81(1):114-128. PubMed ID: 33158815
[TBL] [Abstract][Full Text] [Related]
30. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
31. Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas.
Higgins DMO; Caliva M; Schroeder M; Carlson B; Upadhyayula PS; Milligan BD; Cheshier SH; Weissman IL; Sarkaria JN; Meyer FB; Henley JR
BMC Cancer; 2020 Dec; 20(1):1213. PubMed ID: 33302912
[TBL] [Abstract][Full Text] [Related]
32. Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice.
Wang T; Nowrangi D; Yu L; Lu T; Tang J; Han B; Ding Y; Fu F; Zhang JH
J Neuroinflammation; 2018 Jan; 15(1):2. PubMed ID: 29301581
[TBL] [Abstract][Full Text] [Related]
33. CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.
Fukasawa K; Kadota T; Horie T; Tokumura K; Terada R; Kitaguchi Y; Park G; Ochiai S; Iwahashi S; Okayama Y; Hiraiwa M; Yamada T; Iezaki T; Kaneda K; Yamamoto M; Kitao T; Shirahase H; Hazawa M; Wong RW; Todo T; Hirao A; Hinoi E
Oncogene; 2021 Apr; 40(15):2803-2815. PubMed ID: 33727660
[TBL] [Abstract][Full Text] [Related]
34. shRNA-mediated PPARα knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growth.
Haynes HR; Scott HL; Killick-Cole CL; Shaw G; Brend T; Hares KM; Redondo J; Kemp KC; Ballesteros LS; Herman A; Cordero-Llana O; Singleton WG; Mills F; Batstone T; Bulstrode H; Kauppinen RA; Wurdak H; Uney JB; Short SC; Wilkins A; Kurian KM
J Pathol; 2019 Apr; 247(4):422-434. PubMed ID: 30565681
[TBL] [Abstract][Full Text] [Related]
35. UHRF1-KAT7-mediated regulation of TUSC3 expression via histone methylation/acetylation is critical for the proliferation of colon cancer cells.
Taniue K; Hayashi T; Kamoshida Y; Kurimoto A; Takeda Y; Negishi L; Iwasaki K; Kawamura Y; Goshima N; Akiyama T
Oncogene; 2020 Jan; 39(5):1018-1030. PubMed ID: 31582837
[TBL] [Abstract][Full Text] [Related]
36. Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention.
Wang X; Han M; Wang S; Sun Y; Zhao W; Xue Z; Liang X; Huang B; Li G; Chen A; Li X; Wang J
Theranostics; 2022; 12(12):5451-5469. PubMed ID: 35910786
[No Abstract] [Full Text] [Related]
37. Dickkopf-1 promotes Vascular Smooth Muscle Cell proliferation and migration through upregulating UHRF1 during Cyclic Stretch application.
Zheng TF; Liu XL; Li X; Wang QQ; Zhao YC; Li X; Li MM; Zhang Y; Zhang M; Zhang WC; Zhang C; Zhang Y; Zhang M
Int J Biol Sci; 2021; 17(5):1234-1249. PubMed ID: 33867842
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of NUSAP1 inhibits cell proliferation and invasion through downregulation of TOP2A in human glioblastoma.
Hu Y; Xue Z; Qiu C; Feng Z; Qi Q; Wang J; Jin W; Zhong Z; Liu X; Li W; Zhang Q; Huang B; Chen A; Wang J; Yang N; Zhou W
Cell Cycle; 2022 Sep; 21(17):1842-1855. PubMed ID: 35532155
[TBL] [Abstract][Full Text] [Related]
39. Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC.
Zhang G; Dong Z; Prager BC; Kim LJ; Wu Q; Gimple RC; Wang X; Bao S; Hamerlik P; Rich JN
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30779712
[TBL] [Abstract][Full Text] [Related]
40. PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide.
Higuchi F; Fink AL; Kiyokawa J; Miller JJ; Koerner MVA; Cahill DP; Wakimoto H
Mol Cancer Ther; 2018 Dec; 17(12):2551-2563. PubMed ID: 30217967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
